Local phase III study of Xeloda confirmed stomach cancer therapy.
Roche Korea announced on June 7 that Prof. Kang Yun-goo of the oncology department of Seoul Asan hospital, the chief clinical researcher in a large scal...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
